Lizza Hendriks
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Brain Metastases and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 104
- Lung Cancer Diagnosis and Treatment 45
- Brain Metastases and Treatment 28
- Oncology 116
- Lung Cancer Research Studies 63
- Cancer Immunotherapy and Biomarkers 45
- Colorectal Cancer Treatments and Studies 10
- Co-authors
- Anne‐Marie C. Dingemans (88 shared papers)Benjamin Besse (43 shared papers)David Planchard (19 shared papers)Solange Peters (8 shared papers)Jordi Remón (31 shared papers)Egbert F. Smit (23 shared papers)Dirk De Ruysscher (27 shared papers)Keith M. Kerr (5 shared papers)
- Journals
- Annals of Oncology (28 papers)Journal of Thoracic Oncology (24 papers)Lung Cancer (22 papers)European Journal of Cancer (13 papers)Frontiers in Oncology (13 papers)
- Partner nations
- NetherlandsFranceUnited States
In The Last Decade
Lizza Hendriks
212 papers receiving 5.4k citations
Lizza Hendriks's Hit Papers
Peers
Comparison fields: 5 of 116
- Oncology 2.5k
- Pulmonary and Respiratory Medicine 2.3k
- Cancer Research 449
- Genetics 181
- Immunology 354
Countries citing papers authored by Lizza Hendriks
This map shows the geographic impact of Lizza Hendriks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lizza Hendriks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lizza Hendriks more than expected).
Fields of papers citing papers by Lizza Hendriks
This network shows the impact of papers produced by Lizza Hendriks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lizza Hendriks. The network helps show where Lizza Hendriks may publish in the future.
Co-authors
The 25 scholars most cited alongside Lizza Hendriks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 227 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non–Small-Cell Lung Cancer Hit paper breakdown → | 2018 | 729 |
| 2 | Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Hit paper breakdown → | 2023 | 411 |
| 3 | Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ Hit paper breakdown → | 2021 | 348 |
| 4 | Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Hit paper breakdown → | 2023 | 320 |
| 5 | Non-small-cell lung cancer Hit paper breakdown → | 2024 | 193 |
| 6 | 2008 | 177 | |
| 7 | Immune-checkpoint inhibition for resectable non-small-cell lung cancer — opportunities and challenges Hit paper breakdown → | 2023 | 114 |
| 8 | 2015 | 98 | |
| 9 | 2014 | 95 | |
| 10 | 2015 | 92 | |
| 11 | 2019 | 87 | |
| 12 | 2021 | 86 | |
| 13 | 2020 | 86 | |
| 14 | 2022 | 79 | |
| 15 | 2018 | 72 | |
| 16 | 2022 | 66 | |
| 17 | 2018 | 65 | |
| 18 | 2018 | 62 | |
| 19 | 2016 | 61 | |
| 20 | 2018 | 57 |
About Lizza Hendriks
Lizza Hendriks is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Cancer Research and Surgery, having authored 227 papers that have together received 5.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (104 papers), Lung Cancer Research Studies (63 papers), Cancer Immunotherapy and Biomarkers (45 papers), Lung Cancer Diagnosis and Treatment (45 papers), Brain Metastases and Treatment (28 papers), Cancer Genomics and Diagnostics (15 papers), Radiomics and Machine Learning in Medical Imaging (15 papers) and Colorectal Cancer Treatments and Studies (10 papers). The work is most often cited by research in Oncology (2.5k citations), Pulmonary and Respiratory Medicine (2.3k citations), Cancer Research (449 citations), Genetics (181 citations) and Immunology (354 citations). Lizza Hendriks has collaborated with scholars based in Netherlands, France and United States. Frequent co-authors include Anne‐Marie C. Dingemans, Benjamin Besse, David Planchard, Solange Peters, Jordi Remón, Egbert F. Smit, Dirk De Ruysscher, Keith M. Kerr, Giulia Veronesi and Martin Reck. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, Lung Cancer, European Journal of Cancer and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.